Immediate medical attention is warranted if you develop concerning symptoms, including: Severe or persistent abdominal pain, which may indicate pancreatitisa rare but serious adverse effect of GLP-1 receptor agonists [1] [3] Severe upper abdominal or right-upper-quadrant pain, fever or jaundice, which may indicate gallbladder disease Persistent nausea, vomiting, or diarrhoea leading to dehydration or inability to keep fluids down Signs of hypoglycaemia (if taking concurrent insulin or sulphonylureas)tremor, sweating, confusion, palpitations Unexplained weight gain, particularly if rapid or associated with oedema New or worsening visual symptoms, especially if you have pre-existing diabetic retinopathy A comprehensive medication review should be arranged if you are taking multiple medications, as drug interactions or weight-promoting agents may require adjustment
2017 Jul 4;318(1):33-44, PMID: 28672316 Aleppo G, Ruedy KJ, Riddlesworth TD, Kruger DF, Peter AL, Hirsch I, Bergenstal RM, Toschi E, Ahmann AJ, Shah VN, Rickels MR, Bode BW, Philis-Tsimikas A, Pop-Busui R, Rodriguez H, Eyth E, Bhargava A, Kollman C, Beck RW
"Our goal is to have it available in the coming weeks." [Source: cbc.ca/news/health/ozempic-semaglutide-generic-version-canada-9.7184915] Thomas added that Apotex is working with health insurance companies on coverage
800 mg of berberine
Early evidence, not yet clinical practice While the results are encouraging, important limitations remain
28.Marso SP, Bain SC, Consoli A, et al
